📰 Pharma Two News
Pharma Two News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Two. Real-time updates on events, politics, business and more.
May 30, 2023
/PRNewswire/ -- DelveInsights Parkinsons Disease Market Insights report includes a comprehensive understanding of current treatment practices, Parkinsons...
May 30, 2023
DelveInsight's analysts estimate that the Parkinson's disease market is expected to show positive growth, mainly attributed to increased prevalence and the anticipated launch of novel therapies
May 4, 2023
BOSTON — Treatment with an investigational combination of low-dose pramipexole and rasagiline led to less excessive daytime sleepiness and fewer adverse events compared with pramipexole alone in early Parkinson’s disease, research showed.“In early Parkinson’s disease, there are many side effects associated with dopamine agonists, including excessive daytime sleepiness,
April 26, 2023
An experimental agent combines low-dose, extended-release formulations of two commercially available PD drugs with similar efficacy but with less daytime sleepiness and orthostatic hypotension.
April 23, 2023
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...
December 27, 2021
A phase 3 study evaluating a novel fixed-dose combination of extended release pramipexole and rasagiline (P2B001) in adults with early Parkinson disease met its primary and key secondary endpoints.
December 16, 2021
A phase 3 study evaluating a novel fixed-dose combination of extended release pramipexole and rasagiline (P2B001) in adults with early Parkinson disease met its primary and key secondary endpoints.
December 15, 2021
/PRNewswire/ -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved...
December 15, 2021
/PRNewswire/ -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved...
December 15, 2021
/PRNewswire/ -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved...